Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	47.34	99.65	141.21	106.14	101.42	112.51
Depreciation & Amortization	1.46	1.15	0.8	1.04	1.26	1.48
Stock-Based Compensation	85.71	84.5	61.35	48.94	42.44	42.93
Other Adjustments	-40.63	-41.9	-50.59	-37.3	-30.34	11.43
Change in Receivables	22.75	-5.81	-12.85	-10.07	-3.43	-1.43
Changes in Inventories	-11.36	-7.48	0.31	1.27	1.2	3.44
Changes in Accounts Payable	4.85	25.07	-2.02	5.42	4.76	-3.6
Changes in Accrued Expenses	9.25	4.01	50.78	24.41	5.06	5.22
Changes in Income Taxes Payable	0.3	1.09	3.78	1.21	8.69	0.01
Changes in Other Operating Activities	0.98	-18.29	5.54	-14.38	-10.73	-4.11
Operating Cash Flow	120.1	142	198.3	126.68	120.32	167.89
Operating Cash Flow Growth	-33.02%	-28.39%	56.53%	5.28%	-28.33%	10.48%
Capital Expenditures	-0.31	-0.21	-2.17	-0.14	-0.41	-0.47
Purchases of Investments	-256.79	-319.61	-588.31	-328.75	-355.07	-312.81
Proceeds from Sale of Investments	334.57	389.58	412.88	419.79	241.15	449.4
Investing Cash Flow	77.47	69.76	-177.6	90.91	-114.33	136.13
Issuance of Common Stock	28.56	25.49	9.62	5.81	4.38	16.23
Repurchase of Common Stock	-208.36	-245.86	-37.97	-154.53	-21.67	-318.82
Net Common Stock Issued (Repurchased)	-179.8	-220.37	-28.35	-148.72	-17.28	-302.59
Financing Cash Flow	-179.8	-220.37	-28.35	-148.72	-17.28	-302.59
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.8	1.44	-0.23	0.36	-	-
Net Cash Flow	18.92	-7.17	-7.89	69.22	-11.29	1.43
Free Cash Flow	119.79	141.79	196.12	126.54	119.91	167.42
Free Cash Flow Growth	-15.51%	-27.71%	54.99%	5.53%	-28.38%	11.07%
FCF Margin	15.58%	18.62%	29.05%	26.23%	29.84%	45.75%
Free Cash Flow Per Share	1.03	1.18	1.73	1.13	1.03	1.33
Levered Free Cash Flow	51.85	103.51	196.73	124.33	111.11	114.49
Unlevered Free Cash Flow	-26.9	72.51	176.75	110.25	108.13	114.01

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q